Critical Review: Glucose Health (GLUC) versus Its Peers

Glucose Health (OTCMKTS:GLUC) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its rivals? We will compare Glucose Health to related businesses based on the strength of its analyst recommendations, profitability, valuation, risk, institutional ownership, earnings and dividends.

Insider and Institutional Ownership

16.7% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 22.6% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Glucose Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.21%	-261.73%	-7.59%

Volatility & Risk

Glucose Health has a beta of 3.51, meaning that its share price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s rivals have a beta of 1.47, meaning that their average share price is 47% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Glucose Health and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	555	994	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 47.05%. Given Glucose Health’s rivals higher possible upside, analysts plainly believe Glucose Health has less favorable growth aspects than its rivals.

Valuation & Earnings

This table compares Glucose Health and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-6.13
Glucose Health Competitors	$300.89 million	-$49.81 million	12.99

Glucose Health’s rivals have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Glucose Health rivals beat Glucose Health on 6 of the 10 factors compared.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.